Literature DB >> 29164590

The effect of abdominal obesity in patients with polycystic ovary syndrome on metabolic parameters.

G Franik1, A Bizoń, S Włoch, D Pluta, Ł Blukacz, H Milnerowicz, P Madej.   

Abstract

OBJECTIVE: Polycystic ovarian syndrome and obesity contribute to the metabolic complications for women of reproductive age. The aim of present study was to analyze the effect of abdominal obesity expressed using waist/hip ratio (WHR) in patients with polycystic ovary syndrome on metabolic parameters. PATIENTS AND METHODS: The study included 659 women with PCOS with WHR <0.8 and ≥0.8 aged between 17 and 44 years. Patients were tested for follicular stimulating hormone, luteinizing hormone, 17-beta-estradiol, dehydroepiandrosterone sulfate, androstenedione, sex hormone binding globulin, and total lipid profile during the follicular phase (within 3 and 5 days of their menstrual cycle). Also, fasting glucose and insulin concentrations, and after, oral-glucose glucose administration, were determinate. De Ritis and Castelli index I and II were calculated.
RESULTS: Women with WHR ≥0.8 had higher concentration of glucose and  insulin (both fasting and after 120 min of oral administration of 75 g glucose), as well as HOMA-IR value, than women with WHR value < 0.8. Also, abdominal obesity disorders hormonal parameters. Higher free androgen index and lower concentration of sex hormone binding globulin and dehydroepiandrosterone sulfate were found in female with WHR ≥ 0.8. Follicular stimulating hormone, luteinizing hormone, androstenedione, and 17-beta-estradiol, were on similar level in both groups. Elevation in triglycerides, total cholesterol, and low-density lipoprotein levels, as well as decrease in high density lipoprotein level in serum of women with WHR value ≥ 0.8, were found when compared to women with WHR < 0.8. A statistically significant correlation was found between WHR value and glucose, insulin, sex hormone binding globulin, free androgen index and lipid profile parameters.
CONCLUSIONS: Abdominal obesity causes additional disorders in metabolic and hormonal parameters in PCOS women, which confirmed changes in analyzed parameters between PCOS women with WHR < 0.8 and WHR ≥ 0.8 and statistically significant correlations between WHR value and analyzed parameters.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29164590

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  Body Composition and Characterization of Skinfold Thicknesses from Polycystic Ovary Syndrome Phenotypes. A Preliminar Case-Control Study.

Authors:  María L Sánchez-Ferrer; Ernesto De La Cruz-Sánchez; Julián J Arense-Gonzalo; María T Prieto-Sánchez; Itziar Bernabeu-González; Ana Carmona-Barnosi; Jaime Mendiola; Alberto M Torres-Cantero
Journal:  Int J Environ Res Public Health       Date:  2021-03-14       Impact factor: 3.390

2.  Adiponectin levels and its relation with insulin secretion and insulin sensitivity in a group of sub-Saharan African women with polycystic ovary syndrome.

Authors:  Audrey Synthia Momo; Vicky Jocélyne Ama Moor; Aurel T Tankeu; Falmata Amazia; Guy Sadeu Wafeu; Magellan Guewo-Fokeng; Esther Astrid Mbono Samba; Jan Réné Nkeck; Yannick Djieka; Christelle Chemaga Nkonpawa; Floriane Djapa Tofeun; Serge Guifo; Julius Dohbit Sama; Siméon Pierre Choukem
Journal:  BMC Res Notes       Date:  2022-01-28

3.  Visceral Adiposity Index and Lipid Accumulation Product as diagnostic markers of Metabolic Syndrome in South Indians with Polycystic Ovary Syndrome.

Authors:  Zeinab Naghshband; Lakshmi Kumar; Sonia Mandappa; Ashitha S Niranjana Murthy; Suttur S Malini
Journal:  J Hum Reprod Sci       Date:  2021-08-25

4.  Inflammation and Insulin Resistance in a Group of Sub-Saharan African Women with Polycystic Ovary Syndrome.

Authors:  Christelle Chemaga Nkonpawa; Vicky Jocelyne Ama Moor; Aurel T Tankeu; Audrey Synthia Momo; Guy Sadeu Wafeu; Falmata Amazia; Jan Rene Nkeck; Tasha Manases; Julius Dohbit Sama; Simeon Pierre Choukem
Journal:  J Inflamm Res       Date:  2021-09-15

5.  Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values.

Authors:  Justyna Niepsuj; Grzegorz Franik; Paweł Madej; Agnieszka Piwowar; Anna Bizoń
Journal:  Biomedicines       Date:  2022-06-30

6.  Body Composition and Its Impact on the Hormonal Disturbances in Women with Polycystic Ovary Syndrome.

Authors:  Anna Bizoń; Sylwia Płaczkowska; Justyna Niepsuj; Marta Czwojdzińska; Marcin Leśniewski; Artur Nowak; Dagmara Pluta; Paweł Madej; Agnieszka Piwowar; Grzegorz Franik
Journal:  Nutrients       Date:  2021-11-24       Impact factor: 5.717

7.  Moxibustion combined with characteristic lifestyle intervention of Traditional Chinese Medicine in the treatment of abdominal obesity: A study protocol for a randomized controlled trial.

Authors:  Li-Hua Wang; Wei Huang; Wei Zhou; Li Zhou; Xiao-Li Zhou; Peng Zhou; Yan Yan; Zhong-Yu Zhou; Hua Wang
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.